Neuroprotective effect of magnesium on lipid peroxidation and axonal function after experimental spinal cord injury

Spinal Cord

Volumn 37, Issue 7, 1999, Pages 480-484

  Suzer T ^a,c   Coskun, E ^a   Islekel, H ^b   Tahta, K ^a  

^a PAMUKKALE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b DOKUZ EYLUL UNIVERSITY   (Turkey)

^c PAMUKKALE UNIVERSITY   (Turkey)

Author keywords

Evoked potentials; Lipid peroxidation; Magnesium; Spinal cord injury

Indexed keywords

LIPID PEROXIDE; MAGNESIUM; MAGNESIUM SULFATE; MALONALDEHYDE; SODIUM CHLORIDE;

ANEURYSM CLIP; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EVOKED SOMATOSENSORY RESPONSE; LIPID PEROXIDATION; MALE; NERVE FIBER; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; SPINAL CORD INJURY; STATISTICAL ANALYSIS; SUBCUTANEOUS DRUG ADMINISTRATION; TURKEY (REPUBLIC);

EID: 0032767744     PISSN: 13624393     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.sc.3100874     Document Type: Article

References (43)

1. 1 Ross IB, Tator CH. Spinal cord blood flow and evoked potential responses after treatment with nimodipine or methylprednisolone in spinal cord-injured rats. Neurosurgery 1993; 33: 470-477.
2. 2 Flamm ES et al. Experimental spinal cord injury: treatment with naloxone. Neurosurgery 1982; 10: 227-231.
3. 3 Akdemir H et al. Histopathology of experimental spinal cord trauma. Res Exp Med, 1992; 192: 177-183.
4. 4 Koc RK et al. Effect of methylprednisolone, tirilazad mesylate and vitamin E on lipid peroxidation after experimental spinal cord injury. Spinal Cord 1999; 37: 29-32.
5. 5 Collins WF. A review and update of experimental and clinical studies of spinal cord injury. Paraplegia, 1983; 21: 204-219.
6. + ATPase activity: dose response analysis during 1st hour after contusion injury in the cat. J Neurosurg 1982; 57: 247-253.
7. 7 Fehlings MG, Tator CH, Linden RD. The effect of nimodipine and dextran on axonal function and blood flow following experimental spinal cord injury. J Neurosurg 1989; 71: 403-416.
8. 8 Koc RK et al. Lipid peroxidation in experimental spinal cord injury. Res Exp Medl 1995; 195: 117-123.
9. 9 Braughler JM, Hall ED. Effects of multi-dose methylprednisolone sodium succinate administration on injured cat spinal cord neurofilament degeneration and energy metabolism. J Neurosurg. 1984; 61: 290-295.
10. 10 Halt PS, Swanson RA, Faden AI. Alcohol exacerbates behavioral and neurochemical effects of rat spinal cord trauma. Arch Neurol 1992; 49: 1178-1184.
11. 11 Braughler JM, Duncan LA, Chase RL. Interaction of lipid peroxidation and calcium in the pathogenesis of neuronal injury. Cent Nerv Syst Trauma 1985; 2: 269-283.
12. 12 Marinov MB et al. Neuroprotective effects of preischemia intraarterial magnesium sulfate in reversible focal cerebral ischemia. J Neurosurg 1996; 85: 117-124.
13. 13 Lipton SA, Rosenberg PA. Excitatory amino acids as a final common pathway for neurologic disorders. N Engl J Med 1994; 330: 613-622.
14. 14 McLean RM. Magnesium and its therapeutical uses: a review. Am J Med 1994; 96: 63-76.
15. 15 Belfort MA, Moise Jr KJ. Effects of magnesium sulfate on maternal brain blood flow in preeclampsia: a randomized placebo-controlled study. Am J Obstet Gynecol 1992; 167: 661-666.
16. 16 Nowak L, Bregestovski P, Ascher P. Magnesium gates glutamate-activated channels in mouse central neurones. Nature 1984; 307: 462-465.
17. 17 Garfinkel L, Garfinkel D. Magnesium regulation of the glycolytic pathway and the enzymes involved. Magnesium 1985; 4: 60-72.
18. 18 Ebel H, Günther T. Magnesium metabolism: a review. J Clin Chem Clin Biochem 1980; 18: 257-270.
19. 2+ is associated with irreversible tissue injury after brain trauma. J Biol Chem 1988; 263: 757-761.
20. 20 Kass IS, Cottrell JE, Chambers G. Magnesium and cobalt, not nimodipine, protect neurons against anoxic damage in the rat hyppocampal slice. Anesthesiology 1988; 69: 710-715.
21. 21 Feldman Z et al. Effect of magnesium given 1 hour after head trauma on brain edema and neurological outcome. J Neurosurg 1996; 85: 131-137.
22. 22 Giulian D, Robertson C. Inhibition of mononuclear phagocytes reduces ischemic injury in the spinal cord. Ann Neurol 1990; 27: 33-42.
23. 2+ and ascorbic acid stimulated peroxidation in vitro. J Neurochem 1980; 34: 1630-1638.
24. 24 Ildan F et al. Effects of naloxone on sodium-and potassium-activated and magnesium dependent adenosine-5′-triphosphase activity and lipid peroxidation and early ultrastructural findings after experimental spinal cord injury. Neurosurgery 1995; 36: 797-805.
25. 25 Ducker TB, Kindt GW, Kempe LG, Pathological findings in acute experimental spinal cord trauma. J Neurosurg 1971; 35: 700-798.
26. 26 Nelson E et al. Spinal cord injury: The role of vascular damage in the pathogenesis of central hemorrhagic necrosis. Arch Neurol 1977; 34: 332-333.
27. 27 Hall ED, Wolf DL, Braughler JM. Effects of a single large dose of methylprednisolone sodium succinate on experimental post-traumatic spinal cord ischemia. Dose-response and time-action analysis. J Neurosurg 1984; 61: 124-130.
28. 28 Hall ED. Neuroprotective pharmacology of methylpredinsolone. J Neurosurg 1992; 76: 23-31.
29. 29 Young W, Flamm ES. Effect of high-dose corticosteroid therapy on blood flow, evoked potentials, and extracellular calcium in experimental spinal cord injury. J Neurosurg 1982; 57: 667-673.
30. 30 Faden AI, Jacobs TP, Holaday JW. Endorphins in experimental spinal injury: therapeutic effect of naloxone. Ann Neurol 1981; 10: 326-332.
31. 31 Black et al. Naloxone and experimental spinal cord injury: Part 1 -High dose administration in a static load compression model. Neurosurgery 1986; 19: 905-908.
32. 32 Flamm ES et al. Experimental spinal cord injury treatment with naloxone. Neurosurgery 1982; 10: 227-231.
33. 33 Young W et al. Effect of naloxone on post-traumatic ischemia in experimental spinal contusion. J Neurosurg 1981; 55: 209-219.
34. 34 Guha A, Tator CH, Piper I. Effect of a calcium channel blocker on posttraumatic spinal cord blood flow. J Neurosurg 1987; 66: 423-430.
35. 35 Imamura H, Tator CH. Effect of intrathecal nimodipine on spinal cord blood flow and evoked potentials in the normal or injured cord. Spinal Cord 1998; 36: 497-506.
36. 36 Izumi Y, Poussel S, Pinard E, Seylaz J. Reduction of infract volume by magnesium after middle cerebral artery occlusion in rats. J Cereb Blood Flow Metab 1991; 11: 1025-1030.
37. 37 McIntosh TK, Vink R, Yamakami I, Faden AI. Magnesium protects against neurological deficit after brain injury. Brain Res. 1989; 482: 252-260.
38. 38 Ram Z et al. Magnesium sulfate reverses experimental delayed cerebral vasospasm after subarachnoid hemorrhage in rats. Stroke, 1991; 22; 922-927.
39. 39 Feria M, Abad F, Sanchez A, Abreu P. Magnesium sulphate injected subcutaneously suppresses autonomy in peripherally deafferented rats. Pain 1993; 53: 287-293.
40. 40 Tuzgen S et al. The effect of epidural cooling on lipid peroxidation after experimental spinal cord injury. Spinal Cord 1998; 36: 654-657.
41. 41 Wallace MC, Tator CH. Failure of blood transfusion or naloxone to improve clinical recovery after experimental spinal cord injury. Neurosurgery 1986; 19: 489-494.
42. 42 Nacimiento AC, Bartels M, Loew F. Acute changes in somatosensory evoked potentials following graded experimental spinal cord compression. Surg Neurol 1986; 25: 62-66.
43. 43 Guha A, Tator CH, Smith CR, Piper I. Improvement in posttraumatic spinal cord blood flow with a combination of calcium channel blocker and a vasopressor. J Trauma 1989; 29: 1440-1447.